The targeted therapies erlotinib and cetuximab, in combination with standard chemotherapy regimens, are well tolerated and have very encouraging activity in recurrent/metastatic head and neck squamous cell carcinoma, according to two presentations at the American Society of Clinical Oncology (ASCO) 2007 Annual Meeting in Chicago.
Stereotactic radiotherapy is increasingly gaining favor as an attractive alternative to conventional surgery of the skull base and head and neck.
Oral screening exams are inexpensive, are easy to perform, and have the potential to reduce the annual global mortality for oral cancer by tens of thousands of people.
Vertigo is a complaint that often causes patients to seek a consultation with an otolaryngologist.
Part 2 of this article will discuss treatment options for skull base tumors.
Otolaryngologist Martin L. Hopp, MD, PhD, of Cedars-Sinai Hospital in Los Angeles, believes that in-office computed tomography (CT) scanning is the trifecta of care for otolaryngologists and their patients.
A 48-year-old woman presents to you for bilateral hearing loss, aural fullness, vertigo, nausea/vomiting, and tinnitus of two months’ duration.
Although otolaryngologic surgeons commonly focus on the palate when treating patients with obstructive sleep apnea (OSA), they also need to look at the tongue.
In the past, almost all support for otolaryngology research was provided through the National Institute on Deafness and other Communication Disorders (NIDCD) or its parent institute, the National Institute on Neurological Diseases and Stroke (NINDS).